HomeHealth NewsPhase III success for rocatinlimab in moderate-to-severe eczema

Phase III success for rocatinlimab in moderate-to-severe eczema

November 27, 2025

- Advertisement -

Credit: João Jesus from Pexels

An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel treatment for moderate-to-severe atopic dermatitis (eczema).

…

Click here to view the original article.

Tags
Medical Xpress

- Advertisment -

‘Life will never be the same without her’: Sir Richard Branson shares a heartfelt tribute to his wife, Joan, following her death aged 80

Mother who hit 12-year-old girl outside Perth high school jailed

Phase III success for rocatinlimab in moderate-to-severe eczema

Recently Viewed

Michigan’s high-stakes Democratic primary for US Senate seat too close to call – live updates | US midterm elections 2026

Australian Dental Association: New adults avoid vital dental care | The Examiner

Good Samaritan attacked by gang of children in Sunshine not expected to recover from injuries

North-West farmer jailed for child abuse, drug use cited | The Advocate

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

‘Brain explosion’ ends Raiders’ roller-coaster season

I was convinced I would never have a child due to climate dread. Then I selfishly had one anyway

Could Your Family Hold an Untold Irish Famine Story? Global Irish Famine Way New Jersey Launches Sta…

POPULAR CATEGORY

FOLLOW US

Phase III success for rocatinlimab in moderate-to-severe eczema

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US